Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2536 to 2550 of 8936 results

  1. Pancreatitis (including acute pancreatitis)

    Awaiting development Reference number: GID-QS10085 Expected publication date: TBC

  2. Diverticular disease

    Awaiting development Reference number: GID-QS10086 Expected publication date: TBC

  3. Thyroid disease

    Awaiting development Reference number: GID-QS10088 Expected publication date: TBC

  4. Primary hyperparathyroidism

    Awaiting development Reference number: GID-QS10089 Expected publication date: TBC

  5. Tinnitus

    Awaiting development Reference number: GID-QS10091 Expected publication date: TBC

  6. Pain management (young people and adults)

    Awaiting development Reference number: GID-QS10093 Expected publication date: TBC

  7. Sleep disordered breathing

    Awaiting development Reference number: GID-QS10096 Expected publication date: TBC

  8. Shared decision-making: practical guidance for health and social care professionals

    Awaiting development Reference number: GID-QS10097 Expected publication date: TBC

  9. Gambling

    Awaiting development Reference number: GID-QS10099 Expected publication date: TBC

  10. Gout

    Awaiting development Reference number: GID-QS10100 Expected publication date: TBC

  11. Heart valve disease in adults

    Awaiting development Reference number: GID-QS10101 Expected publication date: TBC

  12. Infant, children and young people's experience of health care

    Awaiting development Reference number: GID-QS10102 Expected publication date: TBC

  13. Sonrotoclax for treating relapsed or refractory mantle cell lymphoma after an anti-CD20 treatment and a BTK inhibitor [ID6654]

    Awaiting development Reference number: GID-TA11866 Expected publication date: TBC

  14. Nerandomilast for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis [ID6446]

    In development Reference number: GID-TA11552 Expected publication date:  09 September 2026

  15. NY-ESO-1 T-cells for treating synovial sarcoma [ID1286]

    In development Reference number: GID-TA10205 Expected publication date: TBC